Wang, Z., Shen, W., Li, X., Feng, Y., Qian, K., Wang, G., . . . Cao, J. (2020). The PPARγ Agonist Rosiglitazone Enhances the Radiosensitivity of Human Pancreatic Cancer Cells. Drug Des Devel Ther.
Citación estilo ChicagoWang, Zhenyu, et al. "The PPARγ Agonist Rosiglitazone Enhances the Radiosensitivity of Human Pancreatic Cancer Cells." Drug Des Devel Ther 2020.
Cita MLAWang, Zhenyu, et al. "The PPARγ Agonist Rosiglitazone Enhances the Radiosensitivity of Human Pancreatic Cancer Cells." Drug Des Devel Ther 2020.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.